Literature DB >> 31563

Improved nutrient absorption after cimetidine in short-bowel syndrome with gastric hypersecretion.

A Cortot, C R Fleming, J R Malagelada.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 31563     DOI: 10.1056/NEJM197901113000207

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  8 in total

1.  Time course of adaptive regulatory peptide changes following massive small bowel resection in the dog.

Authors:  T E Adrian; J S Thompson; E M Quigley
Journal:  Dig Dis Sci       Date:  1996-06       Impact factor: 3.199

2.  Inhibition of gastric secretion relieves diarrhea and postprandial urgency associated with irritable bowel syndrome or functional diarrhea.

Authors:  B Dave; W Rubin
Journal:  Dig Dis Sci       Date:  1999-09       Impact factor: 3.199

3.  Medical staff conference: cimetidine.

Authors:  L H Smith; B Scharschmidt
Journal:  West J Med       Date:  1979-11

4.  Effect of intravenous ranitidine and omeprazole on intestinal absorption of water, sodium, and macronutrients in patients with intestinal resection.

Authors:  P B Jeppesen; M Staun; L Tjellesen; P B Mortensen
Journal:  Gut       Date:  1998-12       Impact factor: 23.059

5.  Ileal resection: effect of cimetidine and taurine on intrajejunal bile acid precipitation and lipid solubilisation.

Authors:  W J Fitzpatrick; P L Zentler-Munro; T C Northfield
Journal:  Gut       Date:  1986-01       Impact factor: 23.059

6.  Gastric acid secretion and gastrin production in the short bowel syndrome.

Authors:  N S Williams; P Evans; R F King
Journal:  Gut       Date:  1985-09       Impact factor: 23.059

7.  Teduglutide, a novel glucagon-like peptide 2 analog, in the treatment of patients with short bowel syndrome.

Authors:  Palle Bekker Jeppesen
Journal:  Therap Adv Gastroenterol       Date:  2012-05       Impact factor: 4.409

Review 8.  Intestinal adaptation in short-bowel syndrome.

Authors:  M J Lentze
Journal:  Eur J Pediatr       Date:  1989-01       Impact factor: 3.183

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.